Emcure and Gennova to resume mRNA collaboration with HDT
India, May 23 -- Mumbai-based Emcure Pharmaceuticalsand its biotech subsidiary,Gennova Biopharmaceuticals have amicably resolved all legal disputes withUS-basedHDT Bio Corp.
According to media reports,a lawsuit was filed by HDT against Emcure accusing it ofstealing trade secretsfrom biopharma company HDT Bio to develop a COVID-19 vaccine.
The litigation between them, including before US courts and the arbitral tribunal in London, has been settled and dismissed. Gennova and HDT, who previously collaborated on the successful development of Gennova's mRNA COVID-19 vaccines will once again collaborate on the development and commercialisation of mRNA vaccines.
The parties have entered into a long-term agreement to develop mRNA vaccines agai...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.